Table 1

Putative roles for BMSCs during infection

Phase 1: Pathogen and damage signal detection 
    BMSCs 
        TLR-mediated modulation of activation and function28-32,34-36,54  
        Recruitment to site of infection through chemotaxis gradients52,54,71  
Phase 2: Activation of host immune response 
    BMSC effects on HSCs 
        Maintenance of quiescent HSC pool56,57  
        BM emigration of activated HSCs57  
    BMSC effects on immune effector cells 
        Mobilization and emigration from BM58  
        Thymic development to augment immune effector cell response79-82  
Phase 3: Pathogen elimination 
    BMSC effects on pathogen 
        Production of microbiocidal soluble factors3,60,61  
        Containment of infectious pathogen within microenvironment (eg, pathogen phagocytosis)62  
        Enhance microbiocidal function of immune effector cells62,83  
Phase 4: Induction of pro-inflammatory gradients 
    BMSC production of immunomodulatory soluble factors 
        Antioxidant soluble factors (HO-1)45,46  
        Anti-inflammatory soluble factors (galectin-1, IDO, IL-10, HGF, HLA-G5, PGE2, TGFβ, TSG-6)2-4,47,52-54,67,72,84  
Phase 5: Modulation of pro-inflammatory host immune response 
    BMSC-mediated effects on host immune response and on immune-induced damage to the host 
        Effects on immune effector cell activation, differentiation, function, or migration47,52-54,73,75,84  
        Augment wound healing, minimize tissue cytotoxicity, or enhance revascularization62-64,71,72  
        Modulation of inflammation and organ dysfunction after in vivo infectious challenge61-64  
Phase 1: Pathogen and damage signal detection 
    BMSCs 
        TLR-mediated modulation of activation and function28-32,34-36,54  
        Recruitment to site of infection through chemotaxis gradients52,54,71  
Phase 2: Activation of host immune response 
    BMSC effects on HSCs 
        Maintenance of quiescent HSC pool56,57  
        BM emigration of activated HSCs57  
    BMSC effects on immune effector cells 
        Mobilization and emigration from BM58  
        Thymic development to augment immune effector cell response79-82  
Phase 3: Pathogen elimination 
    BMSC effects on pathogen 
        Production of microbiocidal soluble factors3,60,61  
        Containment of infectious pathogen within microenvironment (eg, pathogen phagocytosis)62  
        Enhance microbiocidal function of immune effector cells62,83  
Phase 4: Induction of pro-inflammatory gradients 
    BMSC production of immunomodulatory soluble factors 
        Antioxidant soluble factors (HO-1)45,46  
        Anti-inflammatory soluble factors (galectin-1, IDO, IL-10, HGF, HLA-G5, PGE2, TGFβ, TSG-6)2-4,47,52-54,67,72,84  
Phase 5: Modulation of pro-inflammatory host immune response 
    BMSC-mediated effects on host immune response and on immune-induced damage to the host 
        Effects on immune effector cell activation, differentiation, function, or migration47,52-54,73,75,84  
        Augment wound healing, minimize tissue cytotoxicity, or enhance revascularization62-64,71,72  
        Modulation of inflammation and organ dysfunction after in vivo infectious challenge61-64  
Close Modal

or Create an Account

Close Modal
Close Modal